NCT01386853

Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

A 12-week, Randomized, Multicenter, Double-blind, Active-controlled, Non-inferiority Study to Compare the Efficacy and Safety of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Tai Tien Pharmaceuticals Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a 12-week, randomized, multicenter, double-blind, active-controlled, non-inferiority study (TATPITA20101005) to compare the efficacy and safety of pitavastatin (Livalo®) and atorvastatin (Lipitor®) in high risk hypercholesterolemic patients.

Conditions

• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin	2 mg QD
DRUG	Atorvastatin	10 mg QD

Timeline

• Start date: 2011-07-01
• Primary completion: 2012-03-01
• Completion: 2012-07-01
• First posted: 2011-07-01
• Last updated: 2011-07-01

Locations

6 sites across 1 country: Taiwan